Evidence map›Paper›PMID 40407100›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Dementia care in a rapidly aging society.

Karen Eggleston, Daejung Kim

Abstract readReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Dementia care in a rapidly aging society.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Karen EgglestonShorenstein Asia-Pacific Research Center, FSI, Stanford University, Stanford, California, USA.ORCID 0000-0001-8122-7722
Daejung KimDepartment of Health Care Policy Research, Korea Institute for Health and Social Affairs (KIHASA), Sejong City, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAs one of the most rapidly aging societies globally, Korea's efforts to mitigate the social burden of Alzheimer's disease and related dementias (ADRD) may provide valuable insights.

methodsWe conducted a mixed-methods review of studies and policies related to dementia care in Korea over the past 25 years, including quantitative analysis of administrative and comparative data.

resultsEstimates suggest a high social burden from ADRD, with annual costs increasing from 0.9% to 3.8% of gross domestic product between 2019 and 2050. Pilot programs for integrated community care and hospice palliative care reveal the advantages of innovating from a foundation of national health insurance and long-term care insurance, as well as the continuing challenges of appropriately designing programs and incentives for early detection, integrated care, and late-life palliative care. DISCUSSION: A rigorous analysis of programs addressing uneven quality and a study of the impact of integrated care models for home- and community-based services would be valuable. HIGHLIGHTS: A mixed-method review highlights the challenges of rapid aging in Korea. Universal health and long-term care systems support innovation for dementia care. Dementia costs are projected to increase from 0.9% to 3.8% of gross domestic product in 2019-2050. Pilots of integrated community care and hospice palliative care show promise. Rigorous analysis of programs to address uneven quality would be valuable.

Indexed as

AgingDementiaCost of IllnessHumansPalliative CareRepublic of KoreaAlzheimer's diseasecaregivingdementiagender rolesKorealong‐term carelong‐term care insuranceLong‐Term Services and Supports

Identifiers

PMID40407100
PMCPMC12100498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.